-
公开(公告)号：AU2020234533A1
公开(公告)日：2021-09-16
申请号：AU2020234533
申请日：2020-03-11
Applicant: UNIV HEALTH NETWORK
Inventor： BROKX RICHARD , MASON JACQUELINE M , BRAY MARK R
IPC: C07K16/18 , A61K39/395 , C12N15/13 , C12P21/08
Abstract: The invention provides novel anti-TSG-6 antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
-
公开(公告)号：CA3130225A1
公开(公告)日：2020-08-20
申请号：CA3130225
申请日：2020-02-14
Applicant: UNIV HEALTH NETWORK
Inventor： BROKX RICHARD , MASON JACQUELINE M , BRAY MARK R
IPC: C07K16/28 , A61K39/395 , A61P31/00 , A61P35/00 , A61P35/02 , A61P37/02 , C12N5/10 , C12N15/13 , C12P21/08
Abstract: The invention provides novel anti-FCMR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
-
公开(公告)号：SG11202109708TA
公开(公告)日：2021-10-28
申请号：SG11202109708T
申请日：2020-03-11
Applicant: UNIV HEALTH NETWORK
Inventor： BROKX RICHARD , MASON JACQUELINE M , BRAY MARK R
IPC: C07K16/18 , A61K39/395 , C12N15/13 , C12P21/08
Abstract: The invention provides novel anti-TSG-6 antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
-
公开(公告)号：SG11202107663UA
公开(公告)日：2021-08-30
申请号：SG11202107663U
申请日：2020-01-16
Applicant: UNIV HEALTH NETWORK
Inventor： BROKX RICHARD , MASON JACQUELINE M , BRAY MARK R
IPC: A61K39/395 , C07K16/28 , A61P29/00 , A61P35/00 , A61P35/02 , A61P37/02 , A61P37/06 , C12N15/13 , C12P21/08
Abstract: The invention provides novel anti-LILRB3 antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer, autoimmune disease, or allergic inflammation This invention can also be used to modulate osteoclast differentiation.
-
公开(公告)号：AU2020209367A1
公开(公告)日：2021-08-19
申请号：AU2020209367
申请日：2020-01-16
Applicant: UNIV HEALTH NETWORK
Inventor： BROKX RICHARD , MASON JACQUELINE M , BRAY MARK R
IPC: C07K16/28 , A61K39/395 , A61P29/00 , A61P35/00 , A61P35/02 , A61P37/02 , A61P37/06 , C12N15/13 , C12P21/08
Abstract: The invention provides novel anti-LILRB3 antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer, autoimmune disease, or allergic inflammation. This invention can also be used to modulate osteoclast differentiation.
-
Patent Agency Ranking
公开(公告)号：CA3129302A1
公开(公告)日：2020-09-17
申请号：CA3129302
申请日：2020-03-11
Applicant: UNIV HEALTH NETWORK
Inventor： BROKX RICHARD , MASON JACQUELINE M , BRAY MARK R
Abstract: The invention provides novel anti-TSG-6 antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
-
公开(公告)号：HK1243407A1
公开(公告)日：2018-07-13
申请号：HK18102804
申请日：2018-02-27
Applicant: UNIV HEALTH NETWORK
Inventor： LAUFER RADOSLAW , NG GRACE , BROKX RICHARD , PAULS HEINZ W , LI SZE-WAN , MASON JACQUELINE M , BRAY MARK R
IPC: C07D20060101 , A61K20060101 , A61P20060101
-
公开(公告)号：EP3212652A4
公开(公告)日：2018-04-25
申请号：EP15855932
申请日：2015-10-09
Applicant: UNIV HEALTH NETWORK
Inventor： LAUFER RADOSLAW , NG GRACE , BROKX RICHARD , PAULS HEINZ W , LI SZE-WAN , MASON JACQUELINE M , BRAY MARK R
IPC: C07D487/04 , A61K31/519 , A61P29/00 , A61P35/00 , A61P37/06
CPC classification number: A61K31/519 , A61K45/06 , C07D487/04
Abstract: The invention is a compound represented by Structural Formula (I): (I); or a pharmaceutically acceptable salt thereof. Values for the variables are provided herein. Also included is a pharmaceutical composition comprising the compound represented by Structural Formula (I) and a pharmaceutically acceptable carrier or diluent and methods of treating a subject with cancer with the compound of Structural Formula (I).
-
公开(公告)号：SG11202108837WA
公开(公告)日：2021-09-29
申请号：SG11202108837W
申请日：2020-02-14
Applicant: UNIV HEALTH NETWORK
Inventor： BROKX RICHARD , MASON JACQUELINE M , BRAY MARK R
IPC: C07K16/28 , A61K39/395 , A61P31/00 , A61P35/00 , A61P35/02 , A61P37/02 , C12N5/10 , C12N15/13 , C12P21/08
Abstract: The invention provides novel anti-FCMR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
-
公开(公告)号：AU2020222408A1
公开(公告)日：2021-09-09
申请号：AU2020222408
申请日：2020-02-14
Applicant: UNIV HEALTH NETWORK
Inventor： BROKX RICHARD , MASON JACQUELINE M , BRAY MARK R
IPC: C07K16/28 , A61K39/395 , A61P31/00 , A61P35/00 , A61P35/02 , A61P37/02 , C12N5/10 , C12N15/13 , C12P21/08
Abstract: The invention provides novel anti-FCMR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.028 seconds)
